Clinical research
10.4244/EIJ-D-19-00237
•
Dec 20, 2019
Clinical impact of elevated tricuspid valve inflow gradients after transcatheter edge-to-edge tricuspid valve repair
Orban M, Orban M, Braun D, Deseive S, Kupka D, Stocker TJ, Bagaev E, Karam N, Hagl C, Massberg S, Näbauer M, Hausleiter J
free
Clinical research
10.4244/EIJ-D-19-00333
•
Dec 20, 2019
Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation
Badhwar V, Sorajja P, Duncan A, Thourani V, Schaefer U, Grayburn P, Dumonteil N, Babaliaros V, Garatti A, Lessick J, Chuang M, Blanke P, Muller DW
free
Clinical research
10.4244/EIJ-D-19-00206
•
Dec 20, 2019
First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial
Moreu J, Moreno-Gómez R, Perez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat-Santos I
free
Clinical research
10.4244/EIJ-D-19-00202
•
Dec 20, 2019
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys PW, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg G, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F
free
Clinical research
10.4244/EIJ-D-18-01073
•
Dec 20, 2019
Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial
Kuroda K, Otake H, Shinohara M, Kuroda M, Tsuda S, Toba T, Nagano Y, Toh R, Ishida T, Shinke T, Hirata K
free
